From the FDA Medwatch on December 31, 2008: 

Celgene has issued a Dear Healthcare Professional letter describing a controlled clinical study suggesting that Innohep may increase the risk for death, compared to unfractionated heparin when used to treat elderly patients with renal insufficiency. It recommended consideration of alternatives to Innohep when treating these patients for deep vein thrombosis with or without pulmonary embolism.

Read the complete MedWatch 2008 Safety summary, including a link to the Dear Healthcare Professional letter and the December 2 FDA Ongoing Safety Review, at:  

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Innohep

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Tapentadol HCl

Dosage form: Immediate release oral tablets, 50mg, 75mg, 100mg

Manufacturer: Ortho McNeil Janssen

Usage: treatment of moderate to severe acute pain in adults 18 years of age or older.

Approval Date: December 24, 2008

For more information visit http://www.ortho-mcneil.com/ortho-mcneil/012308_press_release.html

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Bimatoprost 0.03%

Dosage form: 0.03% ophthalmic solution

Manufacturer: Allergan

Usage: a prostaglandin analog used to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness, and darkness.

Approval Date: December 24, 2008

For more information visit http://www.latisse.com/

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Amiodarone HCl

Dosage form: 50mg/ml Injectables

Manufacturer: Prism Pharma

Usage: an antiarrhythmic agent indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.

Approval Date: December 24, 2008

For more information visit http://www.nexterone.com/

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Degarelix

Dosage form: Subcutaneous injectables, 80mg, 100mg

Manufacturer: Ferring

Usage: a GnRH receptor antagonist indicated for the treatment of patients with advanced prostate cancer.

Approval Date: December 24, 2008

For more information visit http://www.ferring.com/en/newsroom/pressreleases/2004/Degarelix.htm

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Receive a free trial offer of up to 14 tablets of prescription Aciphex.  You must complete an online form or call 800-965-8229 to give the information.  In addition, you’ll receive a free newsletter, Reflux Digest, as part of the offer. 

Get the details at https://www.refluxdigest.com/showDTCWebRegistration.do?source=ACPACP01

Check out our list of coupons for this drug and others at Rx $$$.

Active ingredient(s): Gadofosveset Trisodium 244mg

Dosage form: Injectables

Manufacturer: Epix Pharma

Usage: For use in MRA imaging of peripheral vascular disease, providing a breakthrough in the physician’s ability to visualize the human vascular system.

Approval Date: December 22, 2008

For more information visit http://www.epixpharma.com/products/vasovist.asp

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

The makers of Keppra is offering the Patient Savings Card.  With the card, you pay the first $25 of your Keppra XR^TM or Keppra^® co-pay, and they pay the remaining out-of-pocket expense up to $30. The Patient Savings Card is valid for each of your next 12 prescriptions.
To participate in the Keppra XR^TM or Keppra^® Patient Savings Program, print this page and present it to the pharmacist along with your prescription. If you have any questions regarding your eligibility or benefits or if you wish to discontinue your participation, call the Keppra XR^TM/Keppra^® Patient Savings Program at 1-800-657-7613 (8:00 AM - 8:00 PM EST, Monday-Friday).

Get the details at http://www.keppraxr.com/about/savings_program.aspx

Check out our list of coupons for this drug and others at Rx $$$.

Active ingredient(s): Zolpidem Tartrate

Dosage form: oral spray, 5mg and 10mg

Manufacturer: Novaldel

Usage: hypnotic for the treatment of insomnia.

Approval Date: December 19, 2008

For more information visit http://www.novadel.com/pipeline/zolpimist.htm

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.

Active ingredient(s): Plerixafor      

Dosage form: Injectables, 20mg/ml

Manufacturer: Genzyme

Usage: to be used in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM).

Approval Date: December 15, 2008

For more information visit http://www.genzyme.com/corp/media/GENZ%20PR-121508.asp#TopOfPage

Disclaimer: All contents published on RxInfoBlog.com is provided for informational and educational purposes only. Like any printed material, it may become out-of-date over time.  The site and its services are not a substitute for professional medical advice and treatment. Always seek the advice of your doctor before making any changes to your diet, health routine, or treatment.